valerates has been researched along with medroxyprogesterone acetate in 1 studies
| Studies (valerates) | Trials (valerates) | Recent Studies (post-2010) (valerates) | Studies (medroxyprogesterone acetate) | Trials (medroxyprogesterone acetate) | Recent Studies (post-2010) (medroxyprogesterone acetate) |
|---|---|---|---|---|---|
| 2,251 | 294 | 457 | 5,123 | 1,115 | 1,099 |
| Protein | Taxonomy | valerates (IC50) | medroxyprogesterone acetate (IC50) |
|---|---|---|---|
| Estrogen receptor | Homo sapiens (human) | 0.924 | |
| Glucocorticoid receptor | Homo sapiens (human) | 0.013 | |
| Progesterone receptor | Homo sapiens (human) | 2.5081 | |
| Glycine receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | 0.019 | |
| Mineralocorticoid receptor | Homo sapiens (human) | 1.197 | |
| Androgen receptor | Homo sapiens (human) | 0.0061 | |
| Androgen receptor | Rattus norvegicus (Norway rat) | 0.279 | |
| Glycine receptor subunit beta | Rattus norvegicus (Norway rat) | 0.019 | |
| Glycine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | 0.019 | |
| Glycine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | 0.019 | |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 1.197 | |
| Aldo-keto reductase family 1 member C3 | Homo sapiens (human) | 1.4059 | |
| Aldo-keto reductase family 1 member C2 | Homo sapiens (human) | 4.0405 | |
| Aldo-keto reductase family 1 member C1 | Homo sapiens (human) | 1.8 | |
| Estrogen receptor beta | Homo sapiens (human) | 0.924 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gallardo, E; Guanes, PP; Pellicer, A; Remohí, J; Simón, C; Valbuena, D | 1 |
1 other study(ies) available for valerates and medroxyprogesterone acetate
| Article | Year |
|---|---|
Age does not affect uterine resistance to vascular flow in patients undergoing oocyte donation.
Topics: Adult; Aging; Analysis of Variance; Arteries; Chorionic Gonadotropin; Estrogens; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Longitudinal Studies; Medroxyprogesterone Acetate; Oocyte Donation; Pregnancy; Pregnancy Rate; Progesterone; Progesterone Congeners; Prospective Studies; Regional Blood Flow; Ultrasonography, Doppler, Color; Uterus; Valerates; Vascular Resistance | 1996 |